Does SECUKINUMAB Cause Skin atrophy? 121 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Skin atrophy have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.
121
Reports of Skin atrophy with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
8
Deaths
39
Hospitalizations
How Dangerous Is Skin atrophy From SECUKINUMAB?
Of the 121 reports, 8 (6.6%) resulted in death, 39 (32.2%) required hospitalization, and 7 (5.8%) were considered life-threatening.
Is Skin atrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 121 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Skin atrophy?
DUPILUMAB (262)
PREDNISONE (258)
ADALIMUMAB (205)
METHOTREXATE (191)
ETANERCEPT (139)
CLOBETASOL (123)
IBRUTINIB (112)
TRIAMCINOLONE ACETONIDE (110)
HYDROCORTISONE (106)
PREDNISOLONE (100)
Which SECUKINUMAB Alternatives Have Lower Skin atrophy Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG